0 followers
Visus Therapeutics is a clinical-stage company in pursuit of developing the world’s first presbyopia-correcting eye drop with the potential to last at least eight hours.
Ben Bergo
Artiva Biotherapeutics
1 follower
Regeneron
92 followers
Idexx Laboratories
7 followers
Thoughtful
1 follower
Charlie Health
5 followers
Sonoma Biotherapeutics
1 follower
Transgender Law Center
3 followers
Augment
3 followers
Antora Energy
2 followers
Novva Data Centers
2 followers
InfStones
2 followers
Explore companies